Pharmaceutical patent issue emerged as a key KORUS FTA agenda.
In a few round of the KORUS FTA talks in Washington DC, the U. S. side called for the patent to be linked with the health registration of new drugs and for the generic drug ap...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
